(Q33395748)

English

Phase II trial of intraperitoneal cisplatin combined with intravenous paclitaxel in patients with ovarian, primary peritoneal and fallopian tube cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Phase II trial of intraperitoneal cisplatin combined with intravenous paclitaxel in patients with ovarian, primary peritoneal and fallopian tube cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

fallopian tube cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

fallopian tube carcinoma

1 reference

based on heuristic

inferred from title

author name string

Lisa M Landrum

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Johnny Hyde

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Robert S Mannel

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

D Scott McMeekin

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kathleen N Moore

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Joan L Walker

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

12 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

122

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

527-531

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.022

7 January 2021

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.022

7 January 2021

Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the G

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.022

7 January 2021

Intraperitoneal therapy for ovarian cancer: why has it not become standard?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.022

7 January 2021

Intraperitoneal chemotherapy in patients with advanced ovarian cancer: the con view

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.022

7 January 2021

Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.022

7 January 2021

Paclitaxel delivered as a 3-hr infusion with cisplatin in patients with gynecologic cancers: unexpected incidence of neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.022

7 January 2021

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.022

7 January 2021

Outpatient platinum-taxane intraperitoneal chemotherapy regimen for ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.022

7 January 2021

An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.022

7 January 2021

Evaluation of an intraperitoneal chemotherapy program implemented at the Princess Margaret Hospital for patients with epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.022

7 January 2021

Clinical features of hypersensitivity reactions to carboplatin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.022

7 January 2021

The complex clinical picture of presumably allergic side effects to cytostatic drugs: symptoms, pathomechanism, reexposure, and desensitization

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.022

7 January 2021

Relationship between cisplatin administration and the development of ototoxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.022

7 January 2021

Ototoxicity after intraperitoneal chemotherapy: a case report

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.022

7 January 2021

Complications associated with intraperitoneal chemotherapy catheters

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.022

7 January 2021

Intraperitoneal chemotherapy strategies in the treatment of epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.022

7 January 2021

Completion of intraperitoneal chemotherapy in advanced ovarian cancer and catheter-related complications.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.022

7 January 2021

Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: a review of complications and completion rates

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.022

7 January 2021

Intraperitoneal chemotherapy: analysis of complications with an implanted subcutaneous port and catheter system

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.022

7 January 2021

Intraperitoneal chemotherapy for ovarian cancer: 2009 goals.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.022

7 January 2021

Identifiers

10.1016/J.YGYNO.2011.05.022

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33395748&oldid=1962666608"